Avacta Group PLC (AVCT)

Currency in GBP
68.50
-2.00(-2.84%)
Closed·
Advertisement
AVCT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
68.3071.00
52 wk Range
30.0092.00
Key Statistics
Bid/Ask
65.00 / 70.00
Prev. Close
70.5
Open
70.5
Day's Range
68.3-71
52 wk Range
30-92
Volume
506.48K
Average Volume (3m)
1.96M
1-Year Change
114.0625%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AVCT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
81.67
Upside
+19.22%
Members' Sentiments
Bearish
Bullish
ProTips
Short term obligations exceed liquid assets

Avacta Group PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 81.67
(+19.22% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Avacta Group PLC Earnings Call Summary for H2/2025

  • Avacta raised £32.5M over 18 months, extending cash runway to early Q1 2027; net cash balance at £16.4M as of April 2026.
  • R&D expenses rose 31.5% YoY to £18.8M, reflecting strategic focus on pre|CISION oncology platform development.
  • Administrative costs declined 16.7% to £10M through cost reduction initiatives; net operating cash outflows improved to £22.64M.
  • Company considering dual Nasdaq listing to attract U.S. investors; remains clinical-stage with no current revenue generation.
  • FY2025-26 EPS guidance at -$0.09 and -$0.08 respectively; management optimistic on clinical trials despite commercialization uncertainties.
Last Updated: 19/05/2026, 15:24
Read Full Transcript

Earnings

Latest Release
19/05/2026
EPS / Forecast
-0.05 / --
Revenue / Forecast
57K / --
EPS Revisions
Last 90 days

Compare AVCT to Peers and Sector

Metrics to compare
AVCT
Peers
Sector
Relationship
P/E Ratio
−8.8x−4.3x−0.4x
PEG Ratio
−0.24−0.100.00
Price/Book
129.6x2.0x2.6x
Price / LTM Sales
2,839.4x12.0x3.0x
Upside (Analyst Target)
22.6%182.9%51.7%
Fair Value Upside
Unlock1.7%8.8%Unlock

Avacta Group Plc, together with its subsidiaries, engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally. The company’s lead product candidate is AVA6000, a peptide drug conjugate form of doxorubicin, which is an approved cancer drug with known severe toxicities. It also develops AVA6103, a peptide drug conjugate technology designed to deliver exatecan, a potent topoisomerase I inhibitor directly to tumors while limiting the exposure of the released exatecan in normal tissues; and AVA7100 that drives localization to fibroblast activation protein expressing tumors. The company was incorporated in 2003 and is headquartered in London, the United Kingdom.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
3.83M0.82%2.62M
Other Institutional Investors
372.13M79.45%254.91M
Public Companies & Retail Investors
92.44M19.74%63.32M
Total
468.4M100.00%320.86M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Hargreaves Lansdown Asset Management Ltd.29.41%137,771,05094,373
Aberdeen Group Plc13.77%64,494,32444,179

People Also Watch

2.45
EUA
-0.81%
145.30
SPCX
-4.51%
0.0175
PREM
-2.78%
11.28
HPOW
+0.71%
115.20
ITM
-1.62%

FAQ

What Is the Avacta Group (London: AVCT) Share Price Today?

The Avacta Group stock price today is 68.50 GBP.

What Stock Exchange Does Avacta Group (AVCT) Trade On?

Avacta Group is listed and trades on the London Stock Exchange.

What Is the Ticker (Stock Symbol) for Avacta Group?

The stock symbol (also called a 'ticker') for Avacta Group is "AVCT."

What Is the Current Avacta Group Market Capitalisation?

As of today, Avacta Group (London: AVCT) market cap is 320.86M GBP.

What Is Avacta Group's (AVCT) Earnings Per Share (TTM)?

The Avacta Group EPS is currently -0.09 (Trailing Twelve Months).

When Is the Next Avacta Group Earnings Date?

Avacta Group's next earnings report will be released on 05/10/2026.

Is AVCT a Buy or Sell From a Technical Analyst Perspective?

Based on today's Avacta Group moving averages and other technical indicators, the daily buy/sell signal for AVCT stock is Strong Sell.

How Many Times Has Avacta Group Stock Split?

Avacta Group has split 1 times. (See the AVCT stock split history page for full effective split date and price information.)

How Many Employees Does Avacta Group Have?

Avacta Group has 81 employees, based on their latest Companies House report.

What is the current trading status of Avacta Group (London: AVCT)?

As of 12/07/2026, Avacta Group (AVCT) is trading at a share price of 68.50 GBP, with a previous close of 70.50 GBP. The stock has fluctuated within a day range of 68.30 GBP to 71.00 GBP, while its 52-week range spans from 30.00 GBP to 92.00 GBP.

What Is Avacta Group (AVCT) Price Target According to Analysts?

The average 12-month price target for Avacta Group is 81.67 GBP, with a high estimate of 101 GBP and a low estimate of 60 GBP. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +19.22% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.